Oncology & Cancer

Patient-reported outcomes predict aromatase inhibitor adherence

If you want to predict which breast cancer patients will most likely stop taking aromatase inhibitors, check out their own responses to the health questions patients commonly answer in cancer clinical trials, according to ...

Oncology & Cancer

USPSTF advises meds to reduce risk for primary breast cancer

The U.S. Preventive Services Task Force (USPSTF) recommends that clinicians offer risk-reducing medications to women at increased risk for breast cancer and at low risk for adverse medication effects. These recommendations ...

page 1 from 12